Learn more about our latest achievements, product updates, and our involvement in research projects
Monsenso and Empano enter a partnership to help unemployed people coping with stress and depression get back into the labor force.
Following a year-long collaboration, Monsenso signs a three-year +10 mio DKK agreement with a global pharmaceutical company. Monsenso’s mobile health solution will be used for real-world data collection across two studies in connection with the launch of a new drug for depression treatment. The studies are expected to start in the first half of 2021 and will run over a three-year period, covering up to 2250 patients and 120 clinicians across Belgium, the Netherlands, the United Kingdom, Switzerland, Italy, Spain, Denmark, Sweden and France.
As a technology leader in mobile health (mHealth) solutions for mental health, Monsenso is ISO 13485 certified. ISO 13485 is the gold standard for medical device companies to ensure the quality, safety and efficacy of products in the medical device field
Monsenso is partnering with pan-European research consortium in the Go Green Routes project supported by Horizon 2020 programme.
Copenhagen, Denmark – 23 July 2020. Monsenso, a technology leader in mobile health (mHealth) solutions for mental health, has received the ISO 27001 re-certification. This is the international standard that describes best practices for an information security management system (ISMS).
Copenhagen Demark – 22 June 2020. The Research Project HedaX, received EUR 16 million from the Danish Innovation Fund to develop a digital platform that can gather and exchange health data. This tool will provide researchers with the basis to offer better, personalised medicine.
Copenhagen, Denmark – 03 June 2020 Monsenso’s offer of DKK 16-20 million new shares have been extremely well received by both professional and private investors, being oversubscribed by 238%.
Interview with Monsenso’s Chairman of the Board Jukka Pertola about his contribution to the company, and its intention to go public on June 2020.
Copenhagen, Denmark – 11 May 2020 Monsenso has published today a company description detailing the company’s share offer and its plans to trade on Nasdaq First North Growth Market Denmark
Copenhagen, Denmark – 28 April 2020 Monsenso, a Danish developer in mobile health solutions for mental health is ready for the stock exchange, after several years of continuous growth.